GlassScriptPhysician profile
Ryan Christopher Banning
NPI 1356845051
$9,927.93
in general payments reported to CMS, 2019-2025
8 companies · $210 in 2025
The $210 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $22.50 · 2023: $9,268 · 2024: $427 · 2025: $210.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $7,500 · Travel and Lodging: $1,490 · Food and Beverage: $916.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $7,500.00 |
| Travel and Lodging | $1,489.52 |
| Food and Beverage | $915.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9,040.19 | 2023 | Davinci Xi, Da Vinci Surgical System |
| Medtronic, INC. | $400.71 | 2023-2025 | Endo Dissect, Ligasure, Progrip |
| Ethicon US, LLC | $266.40 | 2023-2024 | Vistaseal, Stratafix, Ethicon |
| Virtual Incision Corporation | $140.00 | 2024 | Mira |
| Polynovo North America LLC | $27.25 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $22.50 | 2020 | |
| Boston Scientific Corporation | $17.84 | 2025 | Spyglass Discover |
| Kerecis Limited | $13.04 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Banning listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.